Tobacco

Survey responses analyzed by the CDC and FDA showed that 10% of middle and high school students in the United States reported currently using a tobacco product, although use fell among high schoolers over the past year.

A tobacco cessation program was cost-effective and increased smoking cessation rates by 7.4%, a study in the American Journal of Preventive Medicine showed.

Young people who vape, especially those dependent on nicotine, are at higher risk for depression, and primary care physicians should make vaping cessation a priority to improve their mood, according to an expert.

Researchers observed similar outcomes between hypofractionated and conventional radiation therapy among patients with alcohol- and tobacco-associated, locally advanced head and neck cancer, according to phase 3 study results.

Users of both tobacco and cannabis were more likely than nonusers to report anxiety and depression, a recent study in PloS One showed.

By August 2023, the FDA was expected to have a finalized rule to prohibit menthol in cigarettes; however, no ruling has been issued.

Despite normal spirometry results, some adults with more than 20 pack-years of smoking display respiratory symptoms and experience more exacerbations than asymptomatic smokers, according to results published in JAMA.

Electronic health record-based nudges aimed at clinicians appeared to increase tobacco use treatment penetration among patients with cancer during oncology encounters, according to data published in Journal of Clinical Oncology.

Tobacco dependence was greater among adults who smoked cigarettes than adults who used smokeless tobacco and multiple tobacco products, according to results published in Nicotine & Tobacco Research.

Among the estimated 46 million U.S. adults who used tobacco products in 2021, cigarette smoking prevalence decreased while e-cigarette use increased, according to CDC data published in Morbidity and Mortality Weekly Report.